रिकॉर्ड उद्धरण

APA (7 वां संस्करण) प्रशस्ति पत्र
Ali, S., & Ilyas, M. A. (2024). Fezolinetant- A novel NK3R antagonist for treating postmenopausal vasomotor symptoms. Pakistan Medical Association.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र
Ali, Saqib, और Muhammad Affan Ilyas. Fezolinetant- A Novel NK3R Antagonist for Treating Postmenopausal Vasomotor Symptoms. Pakistan Medical Association, 2024.
एमएलए (9वां संस्करण) प्रशस्ति पत्र
Ali, Saqib, और Muhammad Affan Ilyas. Fezolinetant- A Novel NK3R Antagonist for Treating Postmenopausal Vasomotor Symptoms. Pakistan Medical Association, 2024.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.